Early Drug Development Solutions

Efficacy Testing (cellular and animal)<

  • Microbiology
    in vitro studies
        Download PDF
    - MIC determination (NCCLS standard procedures and ATCC reference strain)
    • Bacterial panels include Gram-positive, Gram-negative, and anaerobes.
    • Fungal panels include yeast, and filamentous fungi
    - Cross-resistance studies using panels of strains expressing most known drug resistance mechanisms e.g. efflux, ßlactamase production, etc.
    - De novo resistance development studies
    - Kill-time studies
    - Post-antimicrobial effect (PAE) studies
    - Effect of body milieus on activity
    - Determination of activity on recently collected clinical isolates using over a 4000 bacterial and fungal clinical isolate collection
    - High-throughput screening of activity using the Beckman2000 automated workstation
    - Drug-drug interaction studies



  • Microbiology
    in vivo Efficacy studies (1 compound per week)
        Download PDF
    - Thigh Infection (S. aureus)
    - Systemic acute S. aureus infection model
    - Systemic acute E. coli infection (IP/IV) model
    - Lung S. pneumoniae infection model
    - Systemic acute C. albicans infection model
    - Lung A. fumigatus infection model (Immuncompromized)
    - Systemic A. fumigatus infection model
    - Systemic C. glabrata infection model (Immuncompromized)